Free account + included starter software — credential review typically takes 1–2 business days. See how it works
BENZONATATE 200MG 100 CAP - 200 mg/1 CAPSULE
Request Item

BENZONATATE 200MG 100 CAP

Generic: Benzonatate

BENZONATATE 200MG 100 CAP

NDC:31722-0958-01
Manufacturer:Camber Pharmaceuticals, Inc.
Strength:200 mg/1
Dosage Form:CAPSULE
Route:ORAL

Sign up to see pricing

Licensed pharmacies, clinics, doctor's offices, and veterinary practices get instant account approval

Sign Up — Instant Approval

Drug Information

Identification

Generic Name

Benzonatate

Brand Name

Benzonatate

Labeler / Distributor

Camber Pharmaceuticals, Inc.

Product Type

HUMAN PRESCRIPTION DRUG

Administration

Dosage Form

CAPSULE

Route of Administration

ORAL

FDA Application Number

ANDA211518

Active Ingredients

IngredientStrength
BENZONATATE200 mg/1

Pharmacological Class

Decreased Tracheobronchial Stretch Receptor Activity [PE]Non-narcotic Antitussive

Data sourced from openFDA / DailyMed. For full prescribing information, consult the drug label.

Clinical Drug Information

Indications & Usage

INDICATIONS AND USAGE Benzonatate capsules is indicated for the symptomatic relief of cough.

Warnings

WARNINGS Hypersensitivity Severe hypersensitivity reactions (including bronchospasm, laryngospasm and cardiovascular collapse) have been reported which are possibly related to local anesthesia from sucking or chewing the capsule instead of swallowing it. Severe reactions have required intervention with vasopressor agents and supportive measures. Psychiatric Effects Isolated instances of bizarre behavior, including mental confusion and visual hallucinations, have also been reported in patients taking benzonatate capsules in combination with other prescribed drugs. Accidental Ingestion and Death in Children Keep benzonatate capsules out of reach of children. Accidental ingestion of benzonatate capsules resulting in death has been reported in children below age 10. Signs and symptoms of overdose have been reported within 15-20 minutes and death has been reported within one hour of ingestion. If accidental ingestion occurs, seek medical attention immediately (see OVERDOSAGE).

Dosage & Administration

DOSAGE AND ADMINISTRATION Adults and Children over 10 years of age: Usual dose is one 100 mg or 200 mg capsule three times a day as needed for cough. If necessary to control cough, up to 600 mg daily in three divided doses may be given. B enzonatate capsules should be swallowed whole. Benzonatate capsules are not to be broken, chewed, dissolved, cut or crushed.

Adverse Reactions

ADVERSE REACTIONS Potential Adverse Reactions to benzonatate capsules may include: Hypersensitivity reactions including bronchospasm, laryngospasm, cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule. CNS: sedation; headache; dizziness; mental confusion; visual hallucinations. GI: constipation; nausea; GI upset. Der m atologic: pruritus; skin eruptions. Other: nasal congestion; sensation of burning in the eyes; vague “chilly” sensation; numbness of the chest; hypersensitivity. Deliberate or accidental overdose has resulted in death, particularly in children.

Clinical data sourced from openFDA drug labeling. For complete prescribing information, consult the full drug label.